SCHOTT Pharma AG & Co. KGaA (BIT:1SXP)
Italy · Delayed Price · Currency is EUR 26.65
0.00 (0.00%)
At close: Oct 24, 2025
BIT:1SXP Revenue
SCHOTT Pharma AG & Co. KGaA had revenue of 256.46M EUR in the quarter ending June 30, 2025, with 1.13% growth. This brings the company's revenue in the last twelve months to 975.68M, up 2.86% year-over-year. In the fiscal year ending September 30, 2024, SCHOTT Pharma AG & Co. KGaA had annual revenue of 957.09M with 6.51% growth.
Revenue (ttm)
975.68M
Revenue Growth
+2.86%
P/S Ratio
3.09
Revenue / Employee
204.33K
Employees
4,690
Market Cap
3.01B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2024 | 957.09M | 58.49M | 6.51% |
| Sep 30, 2023 | 898.60M | 77.46M | 9.43% |
| Sep 30, 2022 | 821.14M | 172.48M | 26.59% |
| Sep 30, 2021 | 648.67M | 64.44M | 11.03% |
| Sep 30, 2020 | 584.23M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Stellantis | 146.12B |
| Eni S.p.A. | 86.56B |
| Enel SpA | 77.79B |
| Assicurazioni Generali | 56.79B |
| Intesa Sanpaolo | 25.71B |
| UniCredit | 24.85B |
| Prysmian | 18.98B |
| Leonardo S.p.a. | 18.70B |